Plasma metabolomics of autism spectrum disorder and influence of shared components in proband families
Exposome · 2021
DOI: 10.1093/exposome/osab004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exposome, 2021. Verfasst von Ming Kei Chung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, Harvard Medical School, Harvard University, Boston, MA, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIEHS NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Prevalence of autism spectrum disorder (ASD) has been increasing in the United States in the past decades. The exact mechanisms remain enigmatic, and diagnosis of the disease still relies primarily on assessment of behavior. We first used a case–control design (75 idiopathic cases and 29 controls, enrolled at Boston Children’s Hospital from 2007-2012) to identify plasma biomarkers of ASD through a metabolome-wide association study approach. Then we leveraged a family-based design (31 families) to investigate the influence of shared genetic and environmental components on the autism-associated features. Using untargeted high-resolution mass spectrometry metabolomics platforms, we detected 19 184 features. Of these, 191 were associated with ASD (false discovery rate < 0.05). We putatively annotated 30 features that had an odds ratio (OR) between <0.01 and 5.84. An identified endogenous metabolite, O-phosphotyrosine, was associated with an extremely low autism odds (OR 0.17; 95% confidence interval 0.06-0.39). We also found that glutathione metabolism was associated with ASD (P = 0.048). Correlations of the significant features between proband and parents were low (median = 0.09). Of the 30 annotated features, the median correlations within families (proband–parents) were −0.15 and 0.24 for the endogenous and exogenous metabolites, respectively. We hypothesize that, without feature identification, family-based correlation analysis of autism-associated features can be an alternative way to assist the prioritization of potentially diagnostic features. A panel of ASD diagnostic metabolic markers with high specificity could be derived upon further studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Informatics, Harvard Medical School, Harvard University, Boston, MA, USA.
- Division of Pulmonary Medicine, Clinical Biomarkers Laboratory, Department of Medicine, Emory University, Atlanta, GA, USA.
- Computational Health Informatics Program, Boston Children's Hospital, Boston, MA, USA.
- Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.
ORCID-Profile: Douglas I Walker, Chirag J Patel, Sek Won Kong
Förderung
- NIAID NIH HHS
- NIEHS NIH HHS
- NIMH NIH HHS
- National Institute of Mental Health
- National Institute of Allergy and Infectious Diseases
- National Institute of Environmental Health Sciences
Zitieren
APA
Chung, M. K., Smith, M. R., Lin, Y., Walker, D. I., Jones, D., Patel, C. J., & Kong, S. W. (2021). Plasma metabolomics of autism spectrum disorder and influence of shared components in proband families. Exposome. https://doi.org/10.1093/exposome/osab004
Vancouver
Chung MK, Smith MR, Lin Y, Walker DI, Jones D, Patel CJ, et al. Plasma metabolomics of autism spectrum disorder and influence of shared components in proband families. Exposome. 2021. doi:10.1093/exposome/osab004
BibTeX
@article{Chung2021,
author = {Chung, Ming Kei and Smith, Matthew Ryan and Lin, Yufei and Walker, Douglas I and Jones, Dean and Patel, Chirag J and Kong, Sek Won},
title = {Plasma metabolomics of autism spectrum disorder and influence of shared components in proband families},
journal = {Exposome},
year = {2021},
doi = {10.1093/exposome/osab004}
}
EUVIMED